A randomised controlled study of patients seen in a special nurse-led clinic after gastroscopy investigation for symptoms related to indigestio
Completed
- Conditions
- GastroscopyDigestive Systemgastroscopy
- Registration Number
- ISRCTN08109872
- Lead Sponsor
- Southampton University Hospitals NHS Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 186
Inclusion Criteria
1. Male and female patients with dyspepsia
2. Over 18 years old
3. Undergoing direct access gastroscopy
Exclusion Criteria
There are 2 stages of filtering for exclusion as follows:
1. Before gastroscopy - From referral letters/forms patients with sinister symptoms:
1.1. Anaemia
1.2. Weight loss over half a stone in three months
1.3. Haematemesis
1.4. Dysphagia
1.5. Vomiting
2. After gastroscopy:
2.1. Peptic ulcer
2.2. Tumour
2.3. Severe oesophagitis
2.4. Barrett's oesophagus
2.5. Anatomical abnormality and
2.6. Post-operative stomach
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The difference between the nurse group and GP group after intervention in: <br>1. GLADYS: 8 questions and a total low score equals to least symptoms with a minimum of 0 and maximum 20<br>2. SF-12: Six questions (3 have 2 parts and 1 has 4 parts). A total high score in this measurement denotes better health related general well being with a minimum 0 and maximum 900<br>3. UHD costs 6 months before and after gastroscopy. The UHD cost analysis is based on the price listed in the Drug Tariff (generic items) or MIMS (branded items). They are summed according to class and averaged.
- Secondary Outcome Measures
Name Time Method Compares before and after intervention within same group in: <br>1. GLADYS<br>2. SF-12<br>3. UHD costs